» Articles » PMID: 38995416

Emotional Intelligence: a Novel Predictor of Quality of Life in Patients with Systemic Sclerosis

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2024 Jul 12
PMID 38995416
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic sclerosis (SSc), a chronic systemic autoimmune disease, affects skin and internal organs compromising organ function and leading to significant morbidity and poor health-related quality of life (HrQoL). This cross-sectional study investigated whether HrQoL is influenced by trait emotional intelligence (TEI). Sixty patients with SSc (Female: 86.67%) completed the socio-demographic characteristics form, TEI Questionnaire Short-Form (TEIQue-SF), and Short-Form Health Survey (SF-36). Sixty healthy controls were also completed the TEIQue-SF. A series of multiple linear regression analyses with correlation matrix was used to analyze SF-36 domains as dependent variables with TEI domains (well-being, self-control, emotionality, sociability) as independent variables. The average age of participants was 57.3 ± 12.9 years with a mean disease duration of 7.7 ± 6.7 years. Patients differed from controls in the sociability domain of TEI. TEI global was found to affect the physical and mental component summaries (p < .001), and all 8 dimensions of the HrQoL (p < .001). Age, disease duration, and gastrointestinal manifestations were negatively associated with various components of SF-36. TEI was positively associated with all dimensions of HrQoL. Understanding the relationship between TEI and HrQoL dimensions is important for the support and empowerment of SSc patients, as well as the establishment and implementation of appropriate psychotherapeutic interventions.

References
1.
Sakkas L, Chikanza I, Platsoucas C . Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol. 2006; 2(12):679-85. DOI: 10.1038/ncprheum0346. View

2.
Sakkas L, Katsiari C, Daoussis D, Bogdanos D . The role of B cells in the pathogenesis of systemic sclerosis: an update. Rheumatology (Oxford). 2022; 62(5):1780-1786. DOI: 10.1093/rheumatology/keac578. View

3.
Gabrielli A, Avvedimento E, Krieg T . Scleroderma. N Engl J Med. 2009; 360(19):1989-2003. DOI: 10.1056/NEJMra0806188. View

4.
Denton C, Khanna D . Systemic sclerosis. Lancet. 2017; 390(10103):1685-1699. DOI: 10.1016/S0140-6736(17)30933-9. View

5.
Volkmann E, Andreasson K, Smith V . Systemic sclerosis. Lancet. 2022; 401(10373):304-318. PMC: 9892343. DOI: 10.1016/S0140-6736(22)01692-0. View